Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#109 of 463

Vamil Divan

Guggenheim · Equity Research Analyst
ProvisionalRating since 2023No new ratings since Sep 2025

Analyst rating accuracy & track record

Vamil Divan is an equity research analyst at Guggenheim. Quantellect has scored 21 of their stock calls across 10 companies. Their picks beat their sector 48% of the time over the next 12 months, and their price targets were reached 40% of the time within a year.

Win % vs sector
48%
PT Hit % (12mo)
40%
Avg sector-excess
+0.9%
Scored calls
21
Tickers
10
Tier
Provisional

Track record

Quantellect has scored 21 of Vamil Divan's stock calls across 10 companies, dating back to 2023. Their rated stocks beat their own sector 48% of the time over the next 12 months. On a typical call, a Divan pick returned +0.9% more than its sector over the following year.

Of the scored calls, 21 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
SVRASavara Inc
Buy$11.00Sep 2025+18.5%Miss
VALNValneva SE ADR
Buy$13.00Sep 2025−45.5%Miss
ASMBAssembly Biosciences Inc
Buy$39.00Sep 2025+30.2%Hit
ANIPANI Pharmaceuticals Inc
Buy$114.00Sep 2025−50.8%Miss
PROKProKidney Corp.
Buy$7.00Jul 2025−74.9%Miss
JBIOJade Biosciences, Inc.
Buy$14.00Jun 2025+71.2%Hit
SVRASavara Inc
Buy$8.00May 2025+111.2%Miss
ANIPANI Pharmaceuticals Inc
Buy$86.00May 2025+15.7%Hit
VALNValneva SE ADR
Buy$14.00May 2025−23.7%Miss
UNCYUnicycive Therapeutics Inc
Buy$6.00Apr 2025+5.8%Miss
ANIPANI Pharmaceuticals Inc
Buy$86.00Apr 2025+5.2%Hit
ASMBAssembly Biosciences Inc
Buy$31.00Mar 2025+162.4%Hit
ABSIAbsci Corp
Buy$10.00Mar 2025−2.5%Miss
PFEPfizer Inc
BuyMar 2025+9.9%
ANIPANI Pharmaceuticals Inc
Buy$86.00Mar 2025+18.9%Hit
ABSIAbsci Corp
Buy$10.00Dec 2024−1.1%Miss
ABSIAbsci Corp
Buy$10.00Oct 2024−3.0%Miss
PROKProKidney Corp.
Buy$6.00Sep 2024+0.1%Hit
ANIPANI Pharmaceuticals Inc
Buy$77.00Apr 2024+6.6%Miss
SCYXScynexis Inc
Buy$9.00Apr 2023−70.7%Miss
SCYXScynexis Inc
Buy$8.00Mar 2023−21.6%Miss
Prev1Next
Go to

Vamil Divan: analyst track record FAQ

Is Vamil Divan a good stock analyst?

Yes, by track record. Vamil Divan ranks number 109 of 463 of the analysts Quantellect scores, with a Q Score of 53 out of 100. Past results do not guarantee future ones.

What is Vamil Divan's win rate?

Vamil Divan's win rate is 48%. Across 21 scored calls, their rated stocks beat their sector 48% of the time over the next 12 months. On a typical call they returned +0.9% more than the sector.

What stocks and sectors does Vamil Divan cover?

Vamil Divan covers 10 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Vamil Divan's price targets accurate?

Vamil Divan's price targets are reached within 12 months 40% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Vamil Divan's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Vamil Divan rank among Wall Street analysts?

Vamil Divan ranks number 109 of 463 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.